190 related articles for article (PubMed ID: 21406185)
41. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
Tang YJ; Sun ZL; Wu WG; Xing J; He YF; Xin DM; Han P
Genet Mol Res; 2015 Mar; 14(1):2450-60. PubMed ID: 25867391
[TBL] [Abstract][Full Text] [Related]
42. The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6.
Lu K; Fang XS; Feng LL; Jiang YJ; Zhou XX; Liu X; Li PP; Chen N; Ding M; Wang N; Zhang J; Wang X
Cancer Lett; 2015 Apr; 359(2):250-8. PubMed ID: 25636517
[TBL] [Abstract][Full Text] [Related]
43. Reciprocal activation between IL-6/STAT3 and NOX4/Akt signalings promotes proliferation and survival of non-small cell lung cancer cells.
Li J; Lan T; Zhang C; Zeng C; Hou J; Yang Z; Zhang M; Liu J; Liu B
Oncotarget; 2015 Jan; 6(2):1031-48. PubMed ID: 25504436
[TBL] [Abstract][Full Text] [Related]
44. Fraxetin Suppresses Proliferation of Non-Small-Cell Lung Cancer Cells via Preventing Activation of Signal Transducer and Activator of Transcription 3.
Zhang Y; Wang L; Deng Y; Zhao P; Deng W; Zhang J; Luo J; Li R
Tohoku J Exp Med; 2019 May; 248(1):3-12. PubMed ID: 31080186
[TBL] [Abstract][Full Text] [Related]
45. SCH66336, inhibitor of protein farnesylation, blocks signal transducer and activators of transcription 3 signaling in lung cancer and interacts with a small molecule inhibitor of epidermal growth factor receptor/human epidermal growth factor receptor 2.
Dowlati A; Kluge A; Nethery D; Halmos B; Kern JA
Anticancer Drugs; 2008 Jan; 19(1):9-16. PubMed ID: 18043125
[TBL] [Abstract][Full Text] [Related]
46. Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer.
Kluge A; Dabir S; Kern J; Nethery D; Halmos B; Ma P; Dowlati A
Int J Cancer; 2009 Oct; 125(7):1728-34. PubMed ID: 19569236
[TBL] [Abstract][Full Text] [Related]
47. [Signal transducers and activators of transcription-3 modulates human squamous cell carcinoma invasion via targeting mircoRNA-21 in vitro].
Liu AQ; Li SS; Zhou X; Wang XD; Zhang L
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Sep; 48(9):539-44. PubMed ID: 24314280
[TBL] [Abstract][Full Text] [Related]
48. Small-molecule targeting of signal transducer and activator of transcription (STAT) 3 to treat non-small cell lung cancer.
Lewis KM; Bharadwaj U; Eckols TK; Kolosov M; Kasembeli MM; Fridley C; Siller R; Tweardy DJ
Lung Cancer; 2015 Nov; 90(2):182-90. PubMed ID: 26410177
[TBL] [Abstract][Full Text] [Related]
49. Lung cancer cell line sensitivity to Zoledronic acid is BAX-dependent.
Aoyagi T; Morii T; Ohtsuka K; Ohnishi H; Tajima T; Yoshiyama A; Mochizuki K; Satomi K; Ichimura S
Anticancer Res; 2013 Dec; 33(12):5357-63. PubMed ID: 24324070
[TBL] [Abstract][Full Text] [Related]
50. Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer.
Li Q; Zhang D; Chen X; He L; Li T; Xu X; Li M
Sci Rep; 2015 Nov; 5():16082. PubMed ID: 26542452
[TBL] [Abstract][Full Text] [Related]
51. The IκB Kinase Inhibitor ACHP Targets the STAT3 Signaling Pathway in Human Non-Small Cell Lung Carcinoma Cells.
Lee JH; Mohan CD; Basappa S; Rangappa S; Chinnathambi A; Alahmadi TA; Alharbi SA; Kumar AP; Sethi G; Ahn KS; Rangappa KS
Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31847229
[TBL] [Abstract][Full Text] [Related]
52. Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.
Falamarzian A; Aliabadi HM; Molavi O; Seubert JM; Lai R; Uludağ H; Lavasanifar A
J Biomed Mater Res A; 2014 Sep; 102(9):3216-28. PubMed ID: 24167124
[TBL] [Abstract][Full Text] [Related]
53. Targeting STAT3 signaling overcomes gefitinib resistance in non-small cell lung cancer.
Liu Z; Ma L; Sun Y; Yu W; Wang X
Cell Death Dis; 2021 May; 12(6):561. PubMed ID: 34059647
[TBL] [Abstract][Full Text] [Related]
54. Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors.
Lee SC; Min HY; Jung HJ; Park KH; Hyun SY; Cho J; Woo JK; Kwon SJ; Lee HJ; Johnson FM; Lee HY
Oncogene; 2016 Oct; 35(42):5515-5526. PubMed ID: 27086926
[TBL] [Abstract][Full Text] [Related]
55. Absence of STAT1 disturbs the anticancer effect induced by STAT3 inhibition in head and neck carcinoma cell lines.
Shim SH; Sung MW; Park SW; Heo DS
Int J Mol Med; 2009 Jun; 23(6):805-10. PubMed ID: 19424608
[TBL] [Abstract][Full Text] [Related]
56. BRMS1 regulates apoptosis in non-small cell lung cancer cells.
You J; He X; Ding H; Zhang T
Cell Biochem Biophys; 2015 Jan; 71(1):465-72. PubMed ID: 25182004
[TBL] [Abstract][Full Text] [Related]
57. Enhanced expression of cohesin loading factor NIPBL confers poor prognosis and chemotherapy resistance in non-small cell lung cancer.
Xu W; Ying Y; Shan L; Feng J; Zhang S; Gao Y; Xu X; Yao Y; Zhu C; Mao W
J Transl Med; 2015 May; 13():153. PubMed ID: 25963978
[TBL] [Abstract][Full Text] [Related]
58. The clinical relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer.
Fujita Y; Yagishita S; Hagiwara K; Yoshioka Y; Kosaka N; Takeshita F; Fujiwara T; Tsuta K; Nokihara H; Tamura T; Asamura H; Kawaishi M; Kuwano K; Ochiya T
Mol Ther; 2015 Apr; 23(4):717-27. PubMed ID: 25597412
[TBL] [Abstract][Full Text] [Related]
59. PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapies.
Sen M; Kindsfather A; Danilova L; Zhang F; Colombo R; LaPorte MG; Kurland BF; Huryn DM; Wipf P; Herman JG
Epigenetics; 2020; 15(6-7):604-617. PubMed ID: 31595832
[TBL] [Abstract][Full Text] [Related]
60. Differential sensitivity of A549 non-small lung carcinoma cell responses to epidermal growth factor receptor pathway inhibitors.
Jaramillo ML; Banville M; Collins C; Paul-Roc B; Bourget L; O'Connor-McCourt M
Cancer Biol Ther; 2008 Apr; 7(4):557-68. PubMed ID: 18296914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
